Cargando…
Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients
Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...
Autores principales: | Cassani, Erica, Cancello, Raffaella, Cavanna, Ferruccio, Maestrini, Sabrina, Di Blasio, Anna Maria, Liuzzi, Antonio, Pezzoli, Gianni, Barichella, Michela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135047/ https://www.ncbi.nlm.nih.gov/pubmed/21766000 http://dx.doi.org/10.4061/2011/624764 |
Ejemplares similares
-
Diabetes and Risk of Parkinson’s Disease: A systematic review and meta-analysis
por: Cereda, Emanuele, et al.
Publicado: (2011) -
Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study
por: Cilia, Roberto, et al.
Publicado: (2017) -
Vitamin D Status and Parkinson’s Disease
por: Barichella, Michela, et al.
Publicado: (2022) -
Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
por: Bossolasco, Patrizia, et al.
Publicado: (2017) -
Onset and mortality of Parkinson’s disease in relation to type II diabetes
por: Pezzoli, Gianni, et al.
Publicado: (2022)